NewsIndiaIndia remained vigilant round the clock against COVID-19, took...

India remained vigilant round the clock against COVID-19, took right decisions at right time: PM Modi

-

New Delhi (India): Prime Minister Narendra Modi on Saturday said the country remained vigilant round the clock against the coronavirus and asserted that the Central government took the right decisions at the right time.

Speaking at the launch of the nationwide vaccination drive against the novel coronavirus via video conferencing, PM Modi said that a high-level committee had already been constituted days before the first case of coronavirus was reported in the country.

“India remained vigilant round the clock and took the right decisions at the right time. On January 30, 2020, the first case of coronavirus was reported in India. Two weeks before this, India had already constituted a high-level committee. That day in 2020, we began surveillance. India issued its first advisory on January 17, 2020. India was among the first nations that began screening of travelers at airports,” he said.

The Prime Minister also said that the announcement of the nationwide lockdown in March 2020 was not an easy decision.

“A lockdown was also announced and it was not an easy decision. To keep such a big population at home is impossible, we knew it. We had analyzed the effect of lockdown on the lives and livelihood of people. But the country moved ahead with ‘Jaan hai toh jahaan hai’ and gave priority to saving lives of the countrymen,” he said.

“I also interacted with citizens several times. The arrangement of free food to the poor was made and a supply of essential items including food, gas, and medical supply was ensured. We have set examples for the world at various levels…India’s economy hit by lockdown is also progressing and moving ahead,” he added.

The Prime Minister underlined that India is among the few nations which despite hardships, provided medicines and medical help to over 150 countries around the world.

“Whether it is paracetamol, hydroxychloroquine, or testing equipment, India has made every possible effort to save people of other countries,” he added.

A total of 3006 session sites across all states and union territories were virtually connected during the launch. Around 100 beneficiaries will be vaccinated at each session site on an inaugural day, the union health ministry has said.

The drug regulatory body of India has currently approved two vaccines. Pune-based Serum Institute of India has developed the Covishield vaccine developed by AstraZeneca and Oxford University while the Covaxin has been developed by Hyderabad’s Bharat Biotech in collaboration with the Indian Medical Council of research (ICMR) and National Institute of Virology.

India reported 15,158 new COVID-19 cases, 16,977 discharges, and 175 deaths in the last 24 hours, as per the Union Health Ministry’s data on Saturday. The cumulative caseload in the country reached 1,05,42,841 including 2,11,033 active infections and 1,01,79715 recoveries. The death toll has climbed to 1,52,093. 

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest news

Swiss unanimously votes for same-sex union referendum

GENEVA — In Switzerland, a controversial same-sex marriage referendum has been resoundingly approved by voters of the conservative, rich Alpine...

New Covid surge overwhelms hospitals in parts of US

WASHINGTON, D.C. — According to one of the country's top health officials, the spike in coronavirus cases in the...

China wants effeminate male celebs to man up

WASHINGTON — Macho men are in and effeminate male performers are out as Beijing expands its crackdown on China's entertainment...

Billie Eilish, BTS to perform at climate change concert

Billie Eilish, BTS, and Elton John, among others, will donate their star power to Global Citizen Live on Saturday...

Google faces off EU in court over record $5.1 billion antitrust fine

This week, Google will face the European Commission in a five-day court hearing, appealing a record $5.1 billion fine...

WHO’s Covax misses 2021 target. What went wrong?

The latest supply forecast for Covax – the programme for sharing COVID-19 vaccines around the world – suggests that accelerating vaccination...

Must read

You might also likeRELATED
Recommended to you